A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies

Gelijkaardige items

• New Anticancer Theobromine Derivative Targeting EGFR(WT) and EGFR(T790M): Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies
  door: Elkaeed, Eslam B., et al.
  Gepubliceerd in: (2022)
• A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
  door: Eissa, Ibrahim H., et al.
  Gepubliceerd in: (2023)
• Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and in silico studies
  door: Eissa, Ibrahim H., et al.
  Gepubliceerd in: (2023)
• Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2
  door: Eissa, Ibrahim H., et al.
  Gepubliceerd in: (2023)
• Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach
  door: Eissa, Ibrahim H., et al.
  Gepubliceerd in: (2023)